FDA inspection
Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.: FDA inspection ending May 19, 2017
FDA inspection 1014454 · Official Action Indicated (OAI) · Zhangjiang
Key facts
| Inspection ID | 1014454 |
|---|---|
| Firm | Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. |
| FEI number | 3004060039 |
| Address | NO. 59 Renmin South Road |
| City | Zhangjiang |
| Country | China |
| Fiscal year | 2017 |
| Inspection end date | May 19, 2017 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 534215 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data